Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Farydak and Avastin in recurrent high grade glioma
NCT00859222Phase 2Completed
- Start
- Mar 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in malignant glioma. Started Mar 2009; status: completed.
02
Drugs
panobinostat
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00859222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859222.